Regulatory and academic studies to derive reference values for human health: The case of bisphenol S.
Bisphenol S
Endocrine-disrupting chemical
Health-based guidance value
Policy making
Toxicity
Journal
Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
31
03
2021
revised:
14
10
2021
accepted:
16
10
2021
pubmed:
25
10
2021
medline:
1
4
2022
entrez:
24
10
2021
Statut:
ppublish
Résumé
The close structural analogy of bisphenol (BP) S with BPA, a recognized endocrine-disrupting chemical and a substance of very high concern in the European Union, highlights the need to assess the extent of similarities between the two compounds and carefully scrutinize BPS potential toxicity for human health. This analysis aimed to investigate human health toxicity data regarding BPS, to find a point of departure for the derivation of human guidance values. A systematic and transparent methodology was applied to determine whether European or international reference values have been established for BPS. In the absence of such values, the scientific literature on human health effects was evaluated by focusing on human epidemiological and animal experimental studies. The results were analyzed by target organ/system: male and female reproduction, mammary gland, neurobehavior, and metabolism/obesity. Academic experimental studies were analyzed and compared to regulatory data including subchronic studies and an extended one-generation and reproduction study. In contrast to the regulatory studies, which were performed at dose levels in the mg/kg bw/day range, the academic dataset on specific target organs or systems showed adverse effects for BPS at much lower doses (0.5-10 μg/kg bw/day). A large disparity between the lowest-observed-adverse-effect levels (LOAELs) derived from regulatory and academic studies was observed for BPS, as for BPA. Toxicokinetic data on BPS from animal and human studies were also analyzed and showed a 100-fold higher oral bioavailability compared to BPA in a pig model. The similarities and differences between the two bisphenols, in particular the higher bioavailability of BPS in its active (non-conjugated) form and its potential impact on human health, are discussed. Based on the available experimental data, and for a better human protection, we propose to derive human reference values for exposure to BPS from the N(L)OAELs determined in academic studies.
Identifiants
pubmed: 34688643
pii: S0013-9351(21)01534-6
doi: 10.1016/j.envres.2021.112233
pii:
doi:
Substances chimiques
Benzhydryl Compounds
0
Endocrine Disruptors
0
Phenols
0
Sulfones
0
bis(4-hydroxyphenyl)sulfone
80-09-1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
112233Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.